| Literature DB >> 28639573 |
Tong Hao1, Yue-Hua Liu2, Yuan-Yuan Li1, Yun Lu3, Hong-Yi Xu1.
Abstract
BACKGROUND: Chronic intermittent hypoxia is the most remarkable feature of obstructive sleep apnea/hypopnea syndrome and it can induce the change of hypoxia-inducible factor-1α (HIF-1α) expression and contractile properties in the genioglossus. To clarify the role of HIF-1α in contractile properties of the genioglossus, this study generated and compared high-throughput RNA-sequencing data from genioglossus between HIF-1α conditional knockout (KO) mice and littermate wild-type (WT) mice.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28639573 PMCID: PMC5494921 DOI: 10.4103/0366-6999.208235
Source DB: PubMed Journal: Chin Med J (Engl) ISSN: 0366-6999 Impact factor: 2.628
Figure 1Targeting of HIF-1α gene. (a) Targeting strategy to create HIF-1α allele. (b) PCR analysis of DNA isolated from tails of HIF-1α-KO mice showing WT, heterozygous (HIF-1αflox/-), and homozygous genotypes (HIF-1αflox/flox) for the conditional targeted allele. (c) PCR analysis of DNA isolated from tails of HIF-1α-KO mice showing Cre- and Cre+ genotypes. (d) HIF-1α messenger RNA expressions in various tissues of WT and HIF-1α-KO mice. HIF-1α: Hypoxia-inducible factor-1α; WT: Wild-type; PCR: Polymerase chain reaction; KO: Knockout. *P < 0.05.
Nucleotide sequences of primers used for PCR amplification
| Genes | Forward primer | Reverse primer |
|---|---|---|
| 5’-AACAGCCCTTCTACCACGAC-3’ | 5’-GCTCGGTTTCAGGAGTTTGTA-3’ | |
| 5’-ATGGACCCCAACTGCTCCTGCTCCACC-3’ | 5’-GGCTGCAACTGTATAGGAAGACGCTCG-3’ | |
| 5’-GGTGCAGCATAGCCCGATGT-3’ | 5’-GATATCCTGTGGGCTCTTCGGC-3’ | |
| 5’-CTCACCCTCAAGGGGACCCA-3’ | 5’-CGTAGCTGGAACCTGAGCCG-3’ | |
| 5’-TGCAGGAGCCGCTTTGTGAA-3’ | 5’-AAGGCAGCCGTGAAGCTGTT-3’ | |
| 5’-CAGCAGGTGCAAACCCA-3’ | 5’-GGCTTTCCTGGGAGATCGGC-3’ | |
| 5’-CCTCATGAAGATCCTGACCG-3’ | 5’-TGCCAATAGTGATGACCTGG-3’ |
PCR: Polymerase chain reaction; JUNB: Jun B proto-oncogene; MT1: Metallothionein 1; NR4A2: Nuclear receptor subfamily 4, Group A, member 2; AP4S1: Adaptor-related protein complex AP-4, sigma 1; KCNJ2: Potassium inwardly-rectifying channel, subfamily J, member 2; TIRAP: Toll-interleukin 1 receptor domain-containing adaptor protein.
Figure 2Examination of RNA integrity by denaturing agarose gel electrophoresis. WT: Wild-type; KO: Knockout.
OD of total RNA of genioglossus in WT and HIF-1α-KO mice
| Samples | A260/280 | RIN* | RNA concentration (ng/µl) |
|---|---|---|---|
| WT1 | 1.98 | 8.9 | 1188.0 |
| KO1 | 2.01 | 8.8 | 1212.1 |
| WT2 | 1.97 | 9.2 | 892.3 |
| KO2 | 1.96 | 9.0 | 1024.8 |
| WT3 | 1.99 | 8.9 | 922.3 |
| KO3 | 2.02 | 9.1 | 767.4 |
*High RIN scores (7–10) and a narrow distribution of scores (1–1.5) from an Agilent Bioanalyzer indicated high RNA sample quality. RIN: RNA integrity number; OD: Optical densities; WT: Wild-type; HIF-1α: Hypoxia-inducible factor-1α; KO: Knockout.
Top ten upregulated mRNAs in WT and HIF-1α-KO mice
| Genes | RPKM in WT mice | RPKM in KO mice | Fold changes | |
|---|---|---|---|---|
| 165 | 765 | 2.24 | <0.00001 | |
| 242 | 617 | 1.82 | <0.00001 | |
| 491 | 1105 | 1.77 | <0.00001 | |
| 361 | 753 | 1.59 | <0.00001 | |
| 51 | 145 | 1.56 | <0.00001 | |
| 37 | 91 | 1.55 | <0.00001 | |
| 559 | 943 | 1.50 | <0.00001 | |
| 231 | 609 | 1.48 | <0.00001 | |
| 357 | 698 | 1.48 | <0.00001 | |
| 371 | 575 | 1.42 | 0.00014 |
RPKM: Reads Per Kilobase of exon model per million mapped reads; JUNB: Jun B proto-oncogene; BTG2: B-cell translocation gene 2; SIK1: Salt-inducible kinase 1; MT1: Metallothionein 1; NR4A2: Nuclear receptor subfamily 4, Group A, member 2; UT2R: Urotensin 2 receptor; KLF10: Kruppel-like factor 10; MT2: Metallothionein 2; FOSL2: Fos-like antigen 2; MIDN: Midnolin; WT: Wild type; HIF-1α: Hypoxia-inducible factor-1α; KO: Knockout; mRNA: Messenger RNA.
Top ten downregulated long noncoding RNAs in WT and HIF-1α-KO mice
| Genes | RPKM in WT mice | RPKM in KO mice | Fold change | |
|---|---|---|---|---|
| 1667 | 861 | 0.68 | <0.00001 | |
| 304 | 149 | 0.70 | 0.00028 | |
| 235 | 133 | 0.72 | 0.00024 | |
| 971 | 553 | 0.75 | 0.00260 | |
| 413 | 236 | 0.76 | 0.00240 | |
| 244 | 96 | 0.76 | 0.00370 | |
| 63 | 27 | 0.77 | 0.00290 | |
| 786 | 503 | 0.77 | 0.00380 | |
| 364 | 173 | 0.78 | 0.00820 | |
| 940 | 641 | 0.78 | 0.00075 |
NARF: Nuclear prelamin A recognition factor; AP4S1: Adaptor-related protein complex AP-4, sigma 1; NT5C1A: 5’-nucleotidase, cytosolic IA; KCNJ2: Potassium inwardly-rectifying channel, subfamily J, member 2; MUSK: Muscle, skeletal, receptor tyrosine kinase; SNAPC1: Small nuclear RNA-activating complex, polypeptide 1; LRRC2: Leucine-rich repeat containing 2; TIRAP: Toll-interleukin 1 receptor domain-containing adaptor protein; AMYL: Amylase 1, salivary; FZD7: Frizzled class receptor 7; RPKM: Reads Per Kilobase of exon model per million mapped reads; WT: Wild-type; HIF-1α: Hypoxia-inducible factor-1α; KO: Knockout.
Figure 3Enrichment analysis of GO terms and pathways for DEGs. (a-c) GO analysis according to biological process, cellular component, and molecular function, respectively. (d) Pathway analysis based on the KEGG database. GO: Gene ontology; KEGG: Kyoto Encyclopedia of Genes Pathway; DEG: Differentially expressed gene.
Figure 4Validation of RNA-seq data by qRT-PCR. RNA-seq: RNA-sequencing; qRT-PCR: quantitative reverse transcription-polymerase chain reaction.